Evidence check: AMH in the context of Haut

AMH (Anti-Müllerian Hormone) is a well-established marker of ovarian reserve, but it has no validated role in skin health or dermatology. No robust human studies link circulating AMH levels to skin aging, elasticity, acne, or other cutaneous conditions. While sex hormones like estrogen and testosterone clearly affect skin, AMH is not part of that pathway. Some commercial tests market AMH in the context of 'skin aging' or 'anti-aging', but this is not evidence-based. The evidence level is 'unclear' or 'marketing'. For skin assessment, validated biomarkers such as vitamin D, collagen metabolites, or inflammatory markers are more appropriate. Consumers should be cautious: AMH results cannot guide skincare or predict skin aging. Mechanistic plausibility is lacking, and no clinical guidelines support its use for skin. Always rely on dermatological evaluation rather than unproven hormone tests.